Literature DB >> 20509136

Design and synthesis of thiadiazoles and thiazoles targeting the Bcr-Abl T315I mutant: from docking false positives to ATP-noncompetitive inhibitors.

Marco Radi1, Emmanuele Crespan, Federico Falchi, Vincenzo Bernardo, Samantha Zanoli, Fabrizio Manetti, Silvia Schenone, Giovanni Maga, Maurizio Botta.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20509136     DOI： 10.1002/cmdc.201000066

Source DB:  PubMed          Journal:  ChemMedChem        ISSN： 1860-7179            Impact factor:   3.466


× No keyword cloud information.
  2 in total

1.  Probing the binding site of abl tyrosine kinase using in situ click chemistry.

Authors:  Cristina Peruzzotti; Stella Borrelli; Micol Ventura; Rebecca Pantano; Gaia Fumagalli; Michael S Christodoulou; Damiano Monticelli; Marcello Luzzani; Anna Lucia Fallacara; Cristina Tintori; Maurizio Botta; Daniele Passarella
Journal:  ACS Med Chem Lett       Date:  2013-01-15       Impact factor: 4.345

2.  Bcr-Abl Allosteric Inhibitors: Where We Are and Where We Are Going to.

Authors:  Francesca Carofiglio; Daniela Trisciuzzi; Nicola Gambacorta; Francesco Leonetti; Angela Stefanachi; Orazio Nicolotti
Journal:  Molecules       Date:  2020-09-14       Impact factor: 4.411
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.